Advertisement
Research ArticleDrug Discovery and Translational Medicine

AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase

T. Stevens, K. Ekholm, M. Gränse, M. Lindahl, V. Kozma, C. Jungar, T. Ottosson, H. Falk-Håkansson, A. Churg, J. L. Wright, H. Lal and A. Sanfridson
Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 313-320; DOI: https://doi.org/10.1124/jpet.111.182139
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Research ArticleDrug Discovery and Translational Medicine

Preclinical Pharmacology of AZD9668, a Novel NE Inhibitor

T. Stevens, K. Ekholm, M. Gränse, M. Lindahl, V. Kozma, C. Jungar, T. Ottosson, H. Falk-Håkansson, A. Churg, J. L. Wright, H. Lal and A. Sanfridson
Journal of Pharmacology and Experimental Therapeutics October 1, 2011, 339 (1) 313-320; DOI: https://doi.org/10.1124/jpet.111.182139
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section